Sacubitril/valsartan for the treatment of non-obstructive hypertrophic cardiomyopathy: An open label randomized controlled trial (SILICOFCM).
Velicki L, Popovic D, Okwose NC, Preveden A, Tesic M, Tafelmeier M, Charman SJ, Barlocco F, MacGowan GA, Seferovic PM, Filipovic N, Ristic A, Olivotto I, Maier LS, Jakovljevic DG; SILICOFCM Investigators.
Velicki L, et al. Among authors: jakovljevic dg.
Eur J Heart Fail. 2024 May 27. doi: 10.1002/ejhf.3291. Online ahead of print.
Eur J Heart Fail. 2024.
PMID: 38800948